GHP Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.16M Buy
38,517
+316
+0.8% +$62K 0.3% 112
2026
Q1
$7.49M Sell
38,201
-285
-0.7% -$55.4K 0.31% 112
2025
Q4
$6.68M Sell
38,486
-769
-2% -$140K 0.27% 130
2025
Q3
$7.48M Sell
39,255
-1,247
-3% -$221K 0.31% 110
2025
Q2
$7.28M Buy
40,502
+338
+0.8% +$58.7K 0.32% 113
2025
Q1
$6.8M Buy
40,164
+1,992
+5% +$327K 0.33% 112
2024
Q4
$5.76M Buy
38,172
+2,015
+6% +$313K 0.27% 134
2024
Q3
$5.61M Buy
36,157
+943
+3% +$141K 0.26% 140
2024
Q2
$4.82M Buy
35,214
+1,539
+5% +$211K 0.24% 146
2024
Q1
$4.48M Sell
33,675
-130
-0.4% -$16.9K 0.22% 154
2023
Q4
$4.66M Buy
33,805
+893
+3% +$117K 0.25% 140
2023
Q3
$4.03M Buy
32,912
+1,480
+5% +$197K 0.24% 142
2023
Q2
$4.24M Buy
31,432
+2,664
+9% +$367K 0.25% 141
2023
Q1
$4.07M Buy
28,768
+933
+3% +$133K 0.26% 135
2022
Q4
$4.35M Buy
27,835
+2,538
+10% +$365K 0.29% 124
2022
Q3
$3.1M Buy
25,297
+498
+2% +$65.6K 0.24% 153
2022
Q2
$3.3M Buy
24,799
+1,835
+8% +$250K 0.25% 147
2022
Q1
$3.14M Buy
22,964
+969
+4% +$135K 0.21% 166
2021
Q4
$3.81M Buy
21,995
+1,579
+8% +$240K 0.27% 129
2021
Q3
$2.97M Buy
20,416
+1,617
+9% +$237K 0.24% 140
2021
Q2
$2.48M Buy
18,799
+720
+4% +$94.3K 0.2% 158
2021
Q1
$2.32M Buy
18,079
+249
+1% +$30.7K 0.2% 151
2020
Q4
$2.13M Buy
17,830
+470
+3% +$57.3K 0.2% 147
2020
Q3
$1.99M Buy
17,360
+1,300
+8% +$154K 0.22% 140
2020
Q2
$1.83M Buy
16,060
+2,350
+17% +$249K 0.23% 144
2020
Q1
$1.1M Buy
13,710
+366
+3% +$37.9K 0.17% 160
2019
Q4
$1.43M Buy
13,344
+1,559
+13% +$163K 0.15% 171
2019
Q3
$1.26M Sell
11,785
-1,772
-13% -$182K 0.16% 169
2019
Q2
$1.38M Buy
13,557
+566
+4% +$54.4K 0.17% 163
2019
Q1
$1.17M Buy
12,991
+190
+1% +$16.5K 0.15% 171
2018
Q4
$1.07M Buy
12,801
+2,771
+28% +$260K 0.16% 165
2018
Q3
$1.08M Sell
10,030
-271
-3% -$29.7K 0.14% 175
2018
Q2
$1.13M Buy
10,301
+14
+0.1% +$1.46K 0.16% 162
2018
Q1
$1.03M Buy
10,287
+156
+2% +$16K 0.15% 173
2017
Q4
$998K Buy
10,131
+509
+5% +$48.3K 0.14% 175
2017
Q3
$901K Buy
9,622
+1,439
+18% +$153K 0.14% 181
2017
Q2
$910K Buy
8,183
+478
+6% +$50.5K 0.14% 178
2017
Q1
$757K Sell
7,705
-115
-1% -$11K 0.13% 187
2016
Q4
$719K Buy
7,820
+172
+2% +$14.8K 0.13% 185
2016
Q3
$647K Sell
7,648
-268
-3% -$22.5K 0.13% 185
2016
Q2
$644K Buy
7,916
+64
+0.8% +$4.87K 0.14% 180
2016
Q1
$561K Sell
7,852
-499
-6% -$33.5K 0.13% 191
2015
Q4
$594K Sell
8,351
-168
-2% -$11.3K 0.14% 174
2015
Q3
$524K Hold
8,519
0.14% 176
2015
Q2
$625K Buy
8,519
+354
+4% +$26.1K 0.15% 158
2015
Q1
$627K Buy
8,165
+1
+0% +$72 0.16% 157
2014
Q4
$547K Buy
8,164
+12
+0.1% +$757 0.15% 163
2014
Q3
$495K Buy
8,152
+382
+5% +$23.5K 0.15% 160
2014
Q2
$456K Sell
7,770
-338
-4% -$19.8K 0.13% 172
2014
Q1
$470K Sell
8,108
-146
-2% -$7.83K 0.15% 160
2013
Q4
$442K Sell
8,254
-1,374
-14% -$81.5K 0.15% 162
2013
Q3
$595K Buy
9,628
+492
+5% +$29.4K 0.22% 117
2013
Q2
$554K Buy
+9,136
New +$544K 0.22% 117

Other funds holding DGX

GHP Investment Advisors's DGX Position: Q2 2026 in Review

GHP Investment Advisors increased its Quest Diagnostics (DGX) stake by 0.83% in Q2 2026, buying an estimated $62K and bringing the position to 38,517 shares worth $8.16M. The position accounts for 0.3% of the portfolio, ranked #112.

GHP Investment Advisors first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 411 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • GHP Investment Advisors held 38,517 shares of Quest Diagnostics worth $8.16M as of Q2 2026.
  • GHP Investment Advisors bought 316 Quest Diagnostics shares in Q2 2026, an estimated $62K.
  • Quest Diagnostics made up 0.3% of GHP Investment Advisors's portfolio in Q2 2026, its #112 holding.
  • GHP Investment Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 411 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.